Does recombinant human growth hormone reduce liver fat content in young adults with obesity and NAFLD?
Young adults with obesity and nonalcoholic fatty liver disease (NAFLD)
Recombinant human growth hormone (rhGH)
Liver fat contentsurrogate
Recombinant human growth hormone may reduce liver fat content in young adults with obesity and NAFLD, though larger studies are needed to confirm this effect.
Data from this pilot study suggest that rhGH treatment in young adults with obesity and NAFLD may have benefits to reduce liver fat content, although larger studies are needed to confirm this effect.
Building similarity graph...
Analyzing shared references across papers
Loading...
Chelsea S. Pan
University of California, Los Angeles
Julian Weiß
Duke University Hospital
Lindsay T. Fourman
Massachusetts General Hospital
Clinical Endocrinology
Harvard University
Yale University
Massachusetts General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Pan et al. (Sat,) studied this question.
synapsesocial.com/papers/69d840515c3030ff03d19974 — DOI: https://doi.org/10.1111/cen.14344